Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Connors

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Journal of Virology|May 28, 2003
The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequencesStephen A Migueles, Alisha C Laborico, Hiromi Imamichi, et al.
The Journal of Infectious Diseases|February 21, 2004
HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentationPeter C Chien, Daniel Chen, Pei-De Chen, et al.
Nature Medicine|August 28, 2007
Broad HIV-1 neutralization mediated by CD4-binding site antibodiesYuxing Li, Stephen A Migueles, Brent Welcher, et al.
Journal of Virology|January 27, 2012
HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cellsDaniel Mendoza, Cassandra Royce, Laura E Ruff, et al.
Clinical Immunology (Orlando, Fla.)|March 27, 2012
Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressorsPhilomena Kamya, Benjamin Tallon, Carlos Melendez-Pena, et al.
AIDS Research and Human Retroviruses|April 7, 2007
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitroAudrey L Kinter, Robin Horak, Melanie Sion, et al.
Nature Protocols|September 14, 2013
Isolation of human monoclonal antibodies from peripheral blood B cellsJinghe Huang, Nicole A Doria-Rose, Nancy S Longo, et al.
Journal of Virology|November 6, 2015
A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral TherapyLaura K DeMaster, Xiaohe Liu, D Jake VanBelzen, et al.
Plos Pathogens|March 9, 2011
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I allelesStephen A Migueles, Julia E Rood, Amy M Berkley, et al.
Journal of Virology|March 16, 2012
Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding siteXueling Wu, Charlene Wang, Sijy O'Dell, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Journal of Virology|May 28, 2003
The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequencesStephen A Migueles, Alisha C Laborico, Hiromi Imamichi, et al.
The Journal of Infectious Diseases|February 21, 2004
HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentationPeter C Chien, Daniel Chen, Pei-De Chen, et al.
Nature Medicine|August 28, 2007
Broad HIV-1 neutralization mediated by CD4-binding site antibodiesYuxing Li, Stephen A Migueles, Brent Welcher, et al.
Journal of Virology|January 27, 2012
HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cellsDaniel Mendoza, Cassandra Royce, Laura E Ruff, et al.
Clinical Immunology (Orlando, Fla.)|March 27, 2012
Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressorsPhilomena Kamya, Benjamin Tallon, Carlos Melendez-Pena, et al.
AIDS Research and Human Retroviruses|April 7, 2007
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitroAudrey L Kinter, Robin Horak, Melanie Sion, et al.
Nature Protocols|September 14, 2013
Isolation of human monoclonal antibodies from peripheral blood B cellsJinghe Huang, Nicole A Doria-Rose, Nancy S Longo, et al.
Journal of Virology|November 6, 2015
A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral TherapyLaura K DeMaster, Xiaohe Liu, D Jake VanBelzen, et al.
Plos Pathogens|March 9, 2011
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I allelesStephen A Migueles, Julia E Rood, Amy M Berkley, et al.
Journal of Virology|March 16, 2012
Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding siteXueling Wu, Charlene Wang, Sijy O'Dell, et al.
Pageof 13